This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Gambir
- DrugBank Accession Number
- DB14298
- Background
Gambir is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Catechu
- Gambir (Uncaria Gambir)
- Gambir Leaf
- Nauclea Gambir Leaf
- Ourouparia Gambir Leaf
- Uncaria Gambir Leaf
- Uncaria Gambir Leafy Twig
- Uruparia Gambir Leaf
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Edge Gambir (2 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Ginkgo biloba (.124 mg/1g) + Mucuna pruriens seed (.025 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g) Gel Topical Sensuous Pty Ltd 2015-04-01 Not applicable US 
Edge Gambir (2 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Ginkgo biloba (.124 mg/1g) + Mucuna pruriens seed (.025 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g) Gel Topical Aloe Vera Industries Pty Ltd 2015-04-01 Not applicable US ฟิชเชอร์ แบร์ พิล Gambir (22.22 mg) + Glycyrrhiza glabra (16.67 mg) + Phellodendron amurense bark (33.33 mg) + Tangerine peel (33.33 mg) + Wood creosote (44.44 mg) Pill บริษัท แมคโครฟาร์ จำกัด 2003-09-02 Not applicable Thailand 
ยาเม็ดทรีแบร์-เอ Gambir (22.22 mg) + Glycyrrhiza glabra (16.67 mg) + Phellodendron amurense bark (33.33 mg) + Tangerine peel (33.33 mg) + Wood creosote (22.22 mg) Pill ห้างหุ้นส่วนจำกัด แอล.บี.เอส. แลบบอเรตอรี่ 2010-04-28 Not applicable Thailand ยาเม็ดสามหมี Gambir (22.22 mg) + Cinnamon (2 mg) + Glycyrrhiza glabra (16.67 mg) + Phellodendron amurense bark (33.33 mg) + Tangerine peel (33.33 mg) + Wood creosote (44.44 mg) Tablet, film coated ห้างหุ้นส่วนจำกัด แอล.บี.เอส. แลบบอเรตอรี่ 2011-05-23 2019-10-21 Thailand - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Edge Gambir (2 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Ginkgo biloba (.124 mg/1g) + Mucuna pruriens seed (.025 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g) Gel Topical Sensuous Pty Ltd 2015-04-01 Not applicable US Edge Gambir (2 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Ginkgo biloba (.124 mg/1g) + Mucuna pruriens seed (.025 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g) Gel Topical Aloe Vera Industries Pty Ltd 2015-04-01 Not applicable US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 3NJQ5D8S6N
- CAS number
- 8001-48-7
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Supportive Care Gingivitis 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gel Topical Pill Tablet, film coated Liquid Dental - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 16:53